vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and WEX Inc. (WEX). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $673.8M, roughly 1.5× WEX Inc.). WEX Inc. runs the higher net margin — 11.5% vs -1.1%, a 12.6% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 5.8%). WEX Inc. produced more free cash flow last quarter ($49.5M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 18.7%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

WEX Inc. is a provider of payment processing and information management services to the United States commercial and government vehicle fleet industry. The company is headquartered in Portland, Maine and provides services in the United States, Canada, South America, Europe, Asia, and Australia.

ALHC vs WEX — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.5× larger
ALHC
$1.0B
$673.8M
WEX
Growing faster (revenue YoY)
ALHC
ALHC
+38.6% gap
ALHC
44.4%
5.8%
WEX
Higher net margin
WEX
WEX
12.6% more per $
WEX
11.5%
-1.1%
ALHC
More free cash flow
WEX
WEX
$104.9M more FCF
WEX
$49.5M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
18.7%
WEX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALHC
ALHC
WEX
WEX
Revenue
$1.0B
$673.8M
Net Profit
$-11.0M
$77.7M
Gross Margin
Operating Margin
-1.0%
23.5%
Net Margin
-1.1%
11.5%
Revenue YoY
44.4%
5.8%
Net Profit YoY
64.6%
8.7%
EPS (diluted)
$-0.04
$2.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
WEX
WEX
Q1 26
$673.8M
Q4 25
$1.0B
$465.1M
Q3 25
$993.7M
$481.6M
Q2 25
$1.0B
$454.4M
Q1 25
$926.9M
$444.3M
Q4 24
$701.2M
$440.3M
Q3 24
$692.4M
$479.0M
Q2 24
$681.3M
$478.6M
Net Profit
ALHC
ALHC
WEX
WEX
Q1 26
$77.7M
Q4 25
$-11.0M
$84.2M
Q3 25
$3.7M
$80.3M
Q2 25
$15.7M
$68.1M
Q1 25
$-9.1M
$71.5M
Q4 24
$-31.1M
$63.9M
Q3 24
$-26.4M
$102.9M
Q2 24
$-24.0M
$77.0M
Gross Margin
ALHC
ALHC
WEX
WEX
Q1 26
Q4 25
39.0%
Q3 25
43.0%
Q2 25
40.0%
Q1 25
39.2%
Q4 24
41.5%
Q3 24
48.0%
Q2 24
44.9%
Operating Margin
ALHC
ALHC
WEX
WEX
Q1 26
23.5%
Q4 25
-1.0%
35.7%
Q3 25
0.8%
38.1%
Q2 25
2.2%
34.5%
Q1 25
-0.6%
35.4%
Q4 24
-3.2%
35.7%
Q3 24
-2.8%
41.0%
Q2 24
-2.7%
35.1%
Net Margin
ALHC
ALHC
WEX
WEX
Q1 26
11.5%
Q4 25
-1.1%
18.1%
Q3 25
0.4%
16.7%
Q2 25
1.5%
15.0%
Q1 25
-1.0%
16.1%
Q4 24
-4.4%
14.5%
Q3 24
-3.8%
21.5%
Q2 24
-3.5%
16.1%
EPS (diluted)
ALHC
ALHC
WEX
WEX
Q1 26
$2.22
Q4 25
$-0.04
$2.38
Q3 25
$0.02
$2.30
Q2 25
$0.07
$1.98
Q1 25
$-0.05
$1.81
Q4 24
$-0.15
$1.60
Q3 24
$-0.14
$2.52
Q2 24
$-0.13
$1.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
WEX
WEX
Cash + ST InvestmentsLiquidity on hand
$604.2M
$633.5M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$1.3B
Total Assets
$1.1B
$15.4B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
WEX
WEX
Q1 26
$633.5M
Q4 25
$604.2M
$5.2B
Q3 25
$644.1M
$4.9B
Q2 25
$503.8M
$4.9B
Q1 25
$479.5M
$4.4B
Q4 24
$470.6M
$4.4B
Q3 24
$381.0M
$4.3B
Q2 24
$363.7M
$4.0B
Total Debt
ALHC
ALHC
WEX
WEX
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
WEX
WEX
Q1 26
$1.3B
Q4 25
$179.3M
$1.2B
Q3 25
$161.9M
$1.1B
Q2 25
$141.0M
$978.7M
Q1 25
$108.1M
$810.4M
Q4 24
$99.9M
$1.5B
Q3 24
$114.5M
$1.7B
Q2 24
$123.7M
$1.8B
Total Assets
ALHC
ALHC
WEX
WEX
Q1 26
$15.4B
Q4 25
$1.1B
$14.4B
Q3 25
$1.1B
$14.4B
Q2 25
$1.0B
$14.7B
Q1 25
$895.6M
$14.0B
Q4 24
$782.1M
$13.3B
Q3 24
$692.3M
$14.0B
Q2 24
$716.3M
$14.2B
Debt / Equity
ALHC
ALHC
WEX
WEX
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
WEX
WEX
Operating Cash FlowLast quarter
$-50.4M
Free Cash FlowOCF − Capex
$-55.4M
$49.5M
FCF MarginFCF / Revenue
-5.5%
7.3%
Capex IntensityCapex / Revenue
0.5%
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$877.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
WEX
WEX
Q1 26
Q4 25
$-50.4M
$294.7M
Q3 25
$144.6M
$376.6M
Q2 25
$29.1M
$264.6M
Q1 25
$16.6M
$-481.6M
Q4 24
$-8.7M
$638.4M
Q3 24
$26.2M
$3.3M
Q2 24
$23.5M
$-7.0M
Free Cash Flow
ALHC
ALHC
WEX
WEX
Q1 26
$49.5M
Q4 25
$-55.4M
$256.3M
Q3 25
$139.1M
$341.6M
Q2 25
$21.1M
$230.0M
Q1 25
$8.4M
$-514.2M
Q4 24
$-18.0M
$599.7M
Q3 24
$16.9M
$-31.7M
Q2 24
$11.8M
$-46.6M
FCF Margin
ALHC
ALHC
WEX
WEX
Q1 26
7.3%
Q4 25
-5.5%
55.1%
Q3 25
14.0%
70.9%
Q2 25
2.1%
50.6%
Q1 25
0.9%
-115.7%
Q4 24
-2.6%
136.2%
Q3 24
2.4%
-6.6%
Q2 24
1.7%
-9.7%
Capex Intensity
ALHC
ALHC
WEX
WEX
Q1 26
5.6%
Q4 25
0.5%
8.3%
Q3 25
0.6%
7.3%
Q2 25
0.8%
7.6%
Q1 25
0.9%
7.3%
Q4 24
1.3%
8.8%
Q3 24
1.3%
7.3%
Q2 24
1.7%
8.3%
Cash Conversion
ALHC
ALHC
WEX
WEX
Q1 26
Q4 25
3.50×
Q3 25
38.77×
4.69×
Q2 25
1.86×
3.89×
Q1 25
-6.74×
Q4 24
9.99×
Q3 24
0.03×
Q2 24
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

WEX
WEX

Payment processing revenue$284.2M42%
Account servicing revenue$182.5M27%
Other revenue$127.0M19%
Finance fee revenue$80.1M12%

Related Comparisons